clinician
[용어속성] Term
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review
Review
[키워드] “cytokine storm”
acute respiratory syndrome
Anti-inflammatory
anti-inflammatory drug
Anti-inflammatory drugs
anti-viral drug
approach
benefit
Care
challenge
clinical care
Clinical practice
clinical trial
clinician
complementary
condition
Coronavirus-2
COVID-19
COVID-19 disease
COVID-19 patient
Cytokine storm
develop
disease severity
drug
early stage
effective
effective therapy
effort
Evidence
expected
global pandemic
Host
Hypothesis
immune defense
immunomodulation
immunomodulatory activities
Infection
Inflammation
Inflammatory
introduced
management
morbidity and mortality
narrative
novel coronavirus disease
opportunity
patients
pro-inflammatory cytokine
Replication
Research
response
review
risk
Safe
SARS-CoV-2
SARS-CoV-2 entry
severe cases
Spread
targeting
the disease
therapy
Vaccines
virus
while
worsening
[DOI] 10.3390/jcm9124021 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm9124021 PMC 바로가기 [Article Type] Review
Co-Operative Pain Education and Self-management (COPES) Expanding Treatment for Real-World Access (ExTRA): Pragmatic Trial Protocol
Co-Operating Pain Education and Self-management (COPES) 실세계 접근을 위한 치료 확장 (ExTRA): Pragmatic Trial Protocol
Article
[키워드] access
Affair
Analysis
behavioral therapy
Blinding
can be used
Care
chronic
chronic musculoskeletal pain
chronic pain
Chronic Pain.
clinician
cognitive
cognitive behavioral therapy
collected
COVID-19
Department
Depression
determine
education
effective
effort
Electronic health record
evaluate
evaluation metrics
Factor
finding
form
Health
Health care
Health care system
health record
health system
implementation
intensity
Interactive Voice Response
Intervention
IVR
maintain
male
measure
Musculoskeletal
Musculoskeletal pain
nine
Nonpharmacologic Treatment
outcome
outcomes
outperform
Pain
pain intensity
pain interference
Patient
performed
Pragmatic
pragmatic trial
precedence
preference
Primary outcome
resource
secondary
Secondary outcomes
Self-efficacy
Sleep
symptom severity
synchronous
technology
therapy
Treatment
Trial
veteran
veterans
voice
[DOI] 10.1093/pm/pnaa365 PMC 바로가기 [Article Type] Article
[DOI] 10.1093/pm/pnaa365 PMC 바로가기 [Article Type] Article
Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19
COVID-19 성인 입원 환자의 생존자와 비생존자의 실험실 마커의 시간적 변화
Comparative Study
[키워드] acidity
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
albumin
albumin-globulin ratio
alkaline phosphatase
Analysis
aspartate
Aspartate aminotransferase
base excess
Bicarbonate
Blood
blood cell
blood cell count
C-reactive protein
calcium
carbon dioxide
caused
Cell
changes
changes in
cholesterol
cholinesterase
Clinical characteristics
clinician
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
creatine
creatine kinase
cystatin C
D-dimer
death
Degradation
Degradation product
determine
diagnosed with COVID-19
distribution
eosinophil
Eosinophil count
estimated glomerular filtration rate
Extracellular
Extracellular fluid
FIBRIN
filtration rate
fluorescent
fraction
glomerular filtration rate
Glucose
Haemoglobin
high risk
High-density lipoprotein
High-density lipoprotein cholesterol
Hospitalized
hypersensitive C-reactive protein
immature
Inpatient
International
international normalized ratio
Laboratory
Laboratory test
Laboratory tests
Lactate
lactate dehydrogenase
lipoprotein cholesterol
lymphocyte
Lymphocyte count
Magnesium
marker
mean platelet volume
Mild
monocyte
Myoglobin
neutrophil
neutrophil count
nitrogen
non-survivor
Non-survivors
normalized
occurred
ogen
outbreak
Patient
patient condition
phosphatase
phosphorus
plasma
plasma urea
Platelet
Platelet count
platelet distribution width
prealbumin
procalcitonin
progression
Protein
prothrombin
Prothrombin time
red blood cell
red blood cell count
Result
SARS-CoV − 2
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe disease
significant difference
significant differences
significantly
significantly increased
sodium
supplementary material
survivor
Temporal
Temporal changes
test results
total calcium
Total cholesterol
total protein
Treatment
Triglyceride
urea
urea nitrogen
uric acid
variable
variables
Volume
White blood cell
white blood cell count
width
with COVID-19
Wuhan
[DOI] 10.1186/s12879-020-05678-0 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1186/s12879-020-05678-0 PMC 바로가기 [Article Type] Comparative Study
Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19 A protocol for systematic review and meta analysis
COVID-19 치료에서 Shufeng Jiedu 캡슐의 효능 및 안전성 체계적인 검토 및 메타 분석을 위한 프로토콜
Meta-Analysis
[키워드] Analysis
Chinese
Clinical efficacy
clinician
CNKI
Cochrane Handbook
Cochrane Library
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 treatment
database
eligible
English
Epidemic
Evidence
Guidance
Handbook
Infrastructure
Meta-analysis
outcome
Patient
performed
protocol
Registration
registration number
review
Shufeng Jiedu capsule
systematic review
systematic reviews
Treatment
treatment of COVID-19
VIP
Web of Science
[DOI] 10.1097/MD.0000000000023293 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1097/MD.0000000000023293 PMC 바로가기 [Article Type] Meta-Analysis
Pneumococcal superinfection in COVID-19 patients: A series of 5 cases
코로나19 환자에서 폐렴구균 중복감염 : 5건 연속 발생
Case Reports
[키워드] abnormal
Antibiotic therapy
association
bacterial co-infection
Barcelona
cause
Chest
chest X-ray
Clinical characteristics
clinician
Co-infection
Coinfección
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
COVID19
detect
diagnosed
Diagnosis
Diagnóstico
English
Evolution
FIVE
Frequency
hospital
include
Misdiagnosis
outcome
Pandemia
Patient
PCR
pneumococcal
pneumococcal infection
pneumococcus
Pneumonia
presenting
procalcitonin
radiological
respiratory
respiratory infection
risk
S. pneumoniae
SARS-CoV-2
Spain
Spanish
subsequent
Tratamiento
Treatment
[DOI] 10.1016/j.medcli.2020.05.022 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1016/j.medcli.2020.05.022 PMC 바로가기 [Article Type] Case Reports
Recent updates on COVID-19: A holistic review
Review Article
[키워드] accelerate
Alter
Atypical
cardiovascular disease
caused
changes in
Chloroquine
clinician
Comorbidities
Comorbidity
Coronaviridae family
coronavirus
COVID-19
CT scan
described
diabetes
diagnostics
disease
drug
Epidemic
Epidemiology
globe
Health disparity
help
Host
host cell
immune response
include
infect
Infection
information
medication
MERS
Microbiology
Mutation
mutations
nucleocapsid protein
nucleotide
ORF3a
outbreak
Outbreaks
outcomes
pandemic
pathophysiological
PLPro
positive-sense
provide
qRT-PCR
recent
Receptor binding
Remdesivir
reported
Research
RNA virus
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike protein
Scientific community
serological
Signalling
similarity
Spike protein
strain
the disease
Transmission
vaccination
Vaccines
Virology
virulence
virus
virus replication
viruses
WHO
Wuhan, China
zoonotic origin
[DOI] 10.1016/j.heliyon.2020.e05706 PMC 바로가기 [Article Type] Review Article
[DOI] 10.1016/j.heliyon.2020.e05706 PMC 바로가기 [Article Type] Review Article
Death Cafés for prevention of burnout in intensive care unit employees: study protocol for a randomized controlled trial (STOPTHEBURN)
중환자실 직원의 번아웃 예방을 위한 데스 카페: 무작위 대조 시험(STOPTHEBURN)을 위한 연구 프로토콜
Study Protocol
[키워드] Administered
administration
analyzed
Anxiety
Anxiety Disorder
Behavioral symptoms
Burnout
clinician
Clinicians
collaboration
collected
Community
conducted
control arm
COVID-19
Critical care
Critically ill
Critically ill patient
critically ill patients
death
Death Café
Depression
effective
Enrollment
equivalent
event
events
facilitated
GAD-7
Generalized
Generalized Anxiety Disorder
group
health problems
Healthcare workers
hospital
ICU
include
intensive care
intensive care unit
Intervention
inventory
leads
mental health problems
mitigate
Moral distress
Nurses
Occupational stress
offer
outcome
participant
Participation
patient mortality
patient safety
physician
Prevent
Primary outcome
provide
psychotherapist
Qualitative
Questionnaires
Randomized
Randomized controlled trial
recruited
reduce
Reflection
score
secondary
Secondary outcomes
social interaction
Study protocol
subject
susceptible
syndrome
Teledebriefing
trauma
Trial registration
Virtual debriefing
vulnerable population
Work place retention
[DOI] 10.1186/s13063-020-04929-4 PMC 바로가기 [Article Type] Study Protocol
[DOI] 10.1186/s13063-020-04929-4 PMC 바로가기 [Article Type] Study Protocol
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications
Cell and Developmental Biology
[키워드] ACE2
acute respiratory syndrome
antiviral drug
clinician
Complication
coronavirus
COVID-19
COVID-19 patients
dry cough
Guillain–Barrè syndrome
highlight
immune
immunomodulatory therapy
IMPROVE
induce
Infection
Inflammation
Inflammatory response
management
manifestation
mechanisms
MONITOR
multiple sclerosis
nervous system
Neurological complication
Neurological complications
neurological sign
predominant
respiratory
respiratory symptom
SARS-CoV-2
SARS-COV-2 infection
Specific
stroke
Supportive treatment
Treatment
virus
worldwide pandemic
[DOI] 10.3389/fcell.2020.605972 PMC 바로가기 [Article Type] Cell and Developmental Biology
[DOI] 10.3389/fcell.2020.605972 PMC 바로가기 [Article Type] Cell and Developmental Biology
Serum neopterin levels in relation to mild and severe COVID-19
경증 및 중증 COVID-19와 관련된 혈청 네오프테린 수치
Comparative Study
[키워드] can be used
caused
clinic
clinician
Concentration
coronavirus
coronavirus SARS-CoV-2
Course
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
disease
elevated
help
Hospitalization
identify
immune activation
Inclusion
information
initial
intensive care
Kynurenine
marker
mean value
Mild
Mild disease
Mild symptom
mild symptoms
Neopterin
Patient
patients with SARS
poor prognosis
Prognostic marker
Prognostic markers
Prognostic value
Result
serum
serum levels
Severe case
severe cases
severe COVID-19
severely ill patient
severely ill patients
severity of COVID-19
shown
Tryptophan
were measured
with mild disease
[DOI] 10.1186/s12879-020-05671-7 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1186/s12879-020-05671-7 PMC 바로가기 [Article Type] Comparative Study